© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Urodilatin limits acute reperfusion injury in the isolated rat heart
Servicio de Cardiologìa, Hospital General Universitari Vall dHebron, Passeig Vall dHebron, 119–129, 08035 Barcelona, Spain
* Corresponding author. +34-93-4894038; fax: +34-93-4894032 dgdorado{at}hg.vhebron.es
Objectives: Hypercontracture is an important mechanism of myocyte death during reperfusion. cGMP modulates the sensitivity of contractile myofilaments to Ca2+, and increasing cGMP concentration during the last minutes of anoxia prevents reoxygenation-induced hypercontracture in isolated cardiomyocytes. The purpose of this study was to determine whether stimulation of particulate guanylyl cyclase with the natriuretic peptide urodilatin, given at the time of reperfusion, reduces myocardial necrosis in the rat heart submitted to transient ischemia. Methods: Isolated rat hearts (n=38) were submitted to either 40 or 60 min of no-flow ischemia and 2 h of reperfusion, and were allocated to receive or not receive 0.05 µM urodilatin during the first 15 min of reperfusion or non-reperfusion treatment. Results: A marked reduction in myocardial cGMP concentration was observed in control hearts during reperfusion after 40 or 60 min of ischemia. Urodilatin significantly attenuated cGMP depletion during initial reperfusion, markedly improved contractile recovery after 40 min of ischemia (P<0.0309), and reduced reperfusion-induced increase in left ventricular end-diastolic pressure (P=0.0139), LDH release (P=0.0263), and contraction band necrosis (P=0.0179) after 60 min of ischemia. The beneficial effect of urodilatin was reproduced by the membrane permeable cGMP analog 8-Bromo-cGMP. Conclusions: These results indicate that reduced cGMP concentration may impair myocyte survival during reperfusion. Stimulation of particulate guanylyl cyclase may appear as a new strategy to prevent immediate lethal reperfusion injury.
KEYWORDS Ischemia; Natriuretic peptide; Necrosis; Reperfusion; Second messengers
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Inserte, J. A. Barrabes, V. Hernando, and D. Garcia-Dorado Orphan targets for reperfusion injury Cardiovasc Res, July 15, 2009; 83(2): 169 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuno, N. V. Solenkova, V. Solodushko, T. Dost, Y. Liu, X.-M. Yang, M. V. Cohen, and J. M. Downey Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1288 - H1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Hamid, H. S. Bower, and G. F. Baxter Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2598 - H2606. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moldobaeva, L. E. Welsh-Servinsky, L. A. Shimoda, R. S. Stephens, A. D. Verin, R. M. Tuder, and D. B. Pearse Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L919 - L930. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Garcia-Dorado, A. Rodriguez-Sinovas, M. Ruiz-Meana, J. Inserte, L. Agullo, and A. Cabestrero The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion Cardiovasc Res, May 1, 2006; 70(2): 274 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Abdallah, A. Gkatzoflia, H. Pieper, E. Zoga, S. Walther, S. Kasseckert, M. Schafer, K.D. Schluter, H.M. Piper, and C. Schafer Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury Cardiovasc Res, April 1, 2005; 66(1): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sangawa, K. Nakanishi, K. Ishino, M. Inoue, M. Kawada, and S. Sano Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart Ann. Thorac. Surg., January 1, 2004; 77(1): 233 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, J. Inserte, and J. Soler-Soler Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2170 - H2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Agullo, D. Garcia-Dorado, N. Escalona, J. Inserte, M. Ruiz-Meana, J. A. Barrabes, M. Mirabet, P. Pina, and J. Soler-Soler Hypoxia and acidosis impair cGMP synthesis in microvascular coronary endothelial cells Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H917 - H925. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Garcia-Dorado, M. Ruiz-Meana, F. Padilla, A. Rodriguez-Sinovas, and M. Mirabet Gap junction-mediated intercellular communication in ischemic preconditioning Cardiovasc Res, August 15, 2002; 55(3): 456 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Padilla, D. Garcia-Dorado, L. Agullo, J. A Barrabes, J. Inserte, N. Escalona, M. Meyer, M. Mirabet, P. Pina, and J. Soler-Soler Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs Cardiovasc Res, August 15, 2001; 51(3): 592 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruiz-Meana, D. Garcia-Dorado, S. Lane, P. Pina, J. Inserte, M. Mirabet, and J. Soler-Soler Persistence of gap junction communication during myocardial ischemia Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2563 - H2571. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Padilla, D. Garcia-Dorado, L. Agullo, J. Inserte, A. Paniagua, S. Mirabet, J. A. Barrabes, M. Ruiz-Meana, and J. Soler-Soler L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig Cardiovasc Res, June 1, 2000; 46(3): 412 - 420. [Abstract] [Full Text] [PDF] |
||||




